Skip to main content

Table 1 Patient characteristics

From: A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer

Characteristics

 

n = 22

Age

Median (range)

67.5 (37–75)

Sex, n (%)

Male

20 (90.9)

Female

2 (9.1)

ECOG PS, n (%)

0

4 (18.2)

1

18 (81.8)

Smoking history, n (%)

Never

0 (0.0)

Ever/current

22 (100)

Histology, n (%)

Adenocarcinoma

10 (45.5)

Squamous cell carcinoma

7 (31.8)

NSCLC, NOS

5 (22.7)

Stage (UICC7), n (%)

IIIB

4 (18.2)

IV

18 (81.8)

Postoperative recurrence

0 (0.0)

EGFR mutation, n (%)

Negative

21 (95.5)

Unknown

1 (4.5)

ALK transfusion, n (%)

Negative

20 (90.9)

Unknown

2 (9.1)